18
NPS Score
VS
Astrazeneca PLC Claimed Company
- EMPLOYEE
PARTICIPANTS - 126
- TOTAL
RATINGS
Bristol Myers Squibb
- EMPLOYEE
PARTICIPANTS - 261
- TOTAL
RATINGS
Astrazeneca PLC vs Bristol Myers Squibb
Compare Astrazeneca PLC versus Bristol Myers Squibb for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 126 employees and customers of Astrazeneca PLC and 261 employees and customers of Bristol Myers Squibb.
Astrazeneca PLC
Astrazeneca PLC's brand is ranked #511 in the list of Global Top 1000 Brands, as rated by customers of Astrazeneca PLC. Their current market cap is $230.15B.
Bristol Myers Squibb
Bristol Myers Squibb's brand is ranked #205 in the list of Global Top 1000 Brands, as rated by customers of Bristol Myers Squibb. Their current market cap is $140.58B.
4/5
Product Quality
3.9/5
3.9/5
Pricing
3.7/5
3.8/5
Customer Service
3.8/5
| 49% | Promoters |
|---|---|
| 20% | Passive |
| 31% | Detractors |
27
NPS Score
| 55% | Promoters |
|---|---|
| 17% | Passive |
| 28% | Detractors |
Net Promoter Score
Winner by 9
See how Bristol Myers Squibb compares to its competitors
Working at Astrazeneca PLC vs Working at Bristol Myers Squibb
70 / 100
CEO Rating
78 / 100
CEO Rating
Winner by 8%
Astrazeneca PLC
Astrazeneca PLC doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Bristol Myers Squibb
Employees at Bristol Myers Squibb rate their CEO, Giovanni Caforio, 78/100. This score is 8% higher than the scores of Astrazeneca PLC's CEO, Pascal Soriot. Employees in the Finance and IT departments rate Giovanni Caforio the highest.